The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Neurofilaments: neurobiological foundations for biomarker applications
Open accessAbstract
Interest in neurofilaments has risen sharply in recent years with recognition of their potential as biomarkers of brain injury or neurodegeneration in CSF and blood. This is in the context of a growing appreciation for the complexity of the neurobiology of neurofilaments, new recognition of specialized roles for neurofilaments in synapses and a developing understanding of mechanisms responsible for their turnover. Here we will review the neurobiology of neurofilament proteins, describing current understanding of their structure and function, including recently discovered evidence for their roles in synapses. We will explore emerging understanding of the mechanisms of neurofilament degradation and clearance and review new methods for future elucidation of the kinetics of their turnover in humans. Primary roles of neurofilaments in the pathogenesis of human diseases will be described. With this background, we then will review critically evidence supporting use of neurofilament concentration measures as biomarkers of neuronal injury or degeneration. Finally, we will reflect on major challenges for studies of the neurobiology of intermediate filaments with specific attention to identifying what needs to be learned for more precise use and confident interpretation of neurofilament measures as biomarkers of neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–231 of 231
Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice
Ganay, T., Boizot, A., Burrer, R., Chauvin, J. P., & Bomont, P. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-25 · Cited by 50
Self-citationSanelli, T. R., Ge, W., Leystra‐Lantz, C., & Strong, M. J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.02.018 · Cited by 50
McIntee, F. L., Giannoni, P., Blais, S. P., Sommer, G., Neubert, T. A., Rostagno, A. A., & Ghiso, J. A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00223 · Cited by 45
Genetic and clinical characteristics ofNEFL-related Charcot-Marie-Tooth disease
Horga, A., Laurá, M., Jaunmuktane, Z., Jerath, N. U., Gonzalez, M., Polke, J. M., Poh, R., Blake, J. C., Liu, Y., Wiethoff, S., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315077 · Cited by 45
Beck, R., Deek, J., & Safinya, C. R. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120101 · Cited by 44
Johnson-Kerner, B., Ahmad, F. S., Diaz, A. G., Greene, J. P., Gray, S. J., Samulski, R. J., Chung, W. K., Coster, R. V., Maertens, P. M., Noggle, S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu556 · Cited by 43
Ratnam, J., & Teichberg, V. I. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02936.x · Cited by 41
Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport
Manser, C., Stevenson, A., Banner, S. J., Davies, J., Tudor, E. L., Ono, Y., Leigh, P. N., McLoughlin, D. M., Shaw, C. E., & Miller, C. C. J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.034 · Cited by 40
High CSF neurofilament heavy chain levels in neuromyelitis optica
Miyazawa, I., Nakashima, I., Petzold, A., Fujihara, K., Sato, S., & Itoyama, Y. (2007) · Neurology · doi:10.1212/01.wnl.0000256820.26489.17 · Cited by 39
Degradation of the Intermediate Filament Family by Gigaxonin
Bomont, P. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.07.009 · Cited by 38
Self-citationWeller, R. O., Hawkes, C. A., Carare, R. O., & Hardy, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1416-1 · Cited by 37
Self-citationDivergent and convergent roles for kinases and phosphatases in neurofilament dynamics
Lee, S., Pant, H. C., & SHEA, T. B. (2014) · Journal of Cell Science · doi:10.1242/jcs.153346 · Cited by 36
Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy
Sainio, M. T., Ylikallio, E., Mäenpää, L., Lahtela, J., Mattila, P., Auranen, M., Palmio, J., & Tyynismaa, H. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000244 · Cited by 36
Amor, S., van der Star, B. J., Boscá, I., Raffel, J., Gnanapavan, S., Watchorn, J., Kühle, J., Giovannoni, G., Baker, D., Malaspina, A., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514521887 · Cited by 35
Boizot, A., Talmat-Amar, Y., Morrogh, D., Kuntz, N. L., Halbert, C., Chabrol, B., Houlden, H., Stojkovic, T., Schulman, B. A., Rautenstrauss, B. W., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-47 · Cited by 35
Self-citationJacquier, A., Delorme, C., Belotti, E., Morales, R. J., Solé, G., Dubourg, O., Giroux, M., Maurage, C., Castellani, V., Rebelo, A. P., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0457-1 · Cited by 34
Stabilization of neurofilament transcripts during postnatal development
Schwartz, M. L., Shneidman, P. S., BRUCE, J. S., & Schlaepfer, W. W. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90003-5 · Cited by 33
Schwartz, M. L., BRUCE, J. S., Shneidman, P. S., & Schlaepfer, W. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26364 · Cited by 31
Basak, J. M., Kim, J., Pyatkivskyy, Y., Wildsmith, K. R., Jiang, H., Parsadanian, M., Patterson, B. W., Bateman, R. J., & Holtzman, D. M. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-14 · Cited by 30
Johnson-Kerner, B., Diaz, A. G., Ekins, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140157 · Cited by 30
Yaworsky, P. J., Gardner, D. P., & Kappen, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25112 · Cited by 29
Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
Veyrat‐Durebex, C., Corcia, P., Dangoumau, A., Laumonnier, F., Piver, É., Gordon, P. H., Andres, C. R., Vourc’h, P., & Blasco, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8573-9 · Cited by 28
Expression of Neurofilament Subunits at Neocortical Glutamatergic and GABAergic Synapses
Bragina, L., & Conti, F. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00074 · Cited by 26
Local Acceleration of Neurofilament Transport at Nodes of Ranvier
Walker, C. L., Uchida, A., Li, Y., Trivedi, N., Fenn, J. D., Monsma, P. C., Larivière, R., Julien, J., Jung, P., & Brown, A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2272-18.2018 · Cited by 26
Self-citationNeurofilament light chain: An important step toward a disease biomarker in multiple sclerosis
Berger, T., & Stüve, O. (2019) · Neurology · doi:10.1212/wnl.0000000000007022 · Cited by 24
Dyakin, V. V., Chen, Y., Branch, C. A., Veeranna, Yuan, A., Rao, M., Kumar, A. R., Peterhoff, C. M., & Nixon, R. A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.013 · Cited by 23
Self-citationGiant axonal neuropathy locus refinement to a < 590 kb critical interval
Cavalier, L., BenHamida, C., Amouri, R., Belal, S., Bomont, P., Lagarde, N., Gressin, L., Callen, D. F., Demir, E., Topaloğlu, H., et al. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200476 · Cited by 23
Self-citationProgressive dopaminergic neurodegeneration of substantia nigra in the zitter mutant rat
Nakadate, K., Noda, T., Sakakibara, S., Kumamoto, K., Matsuura, T., Joyce, J. N., & Ueda, S. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0058-8 · Cited by 21
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate
Gafson, A., Savva, C., Thorne, T., David, M., Gómez‐Romero, M., Lewis, M. R., Nicholas, R. S., Heslegrave, A., Zetterberg, H., & Matthews, P. M. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000562 · Cited by 21
Self-citationComorbidity in Multiple Sclerosis
Marrie, R. A. (2016) · International Journal of MS Care · doi:10.7224/1537-2073.2016-086 · Cited by 16
Smerjac, S. M., Zheng, J., Hu, C., & Bizzozero, O. A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2648-y · Cited by 3
Cited by
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Self-citationRecent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Goutman, S. A., Hardiman, O., Al-Chalabi, A., Chió, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00465-8 · Cited by 493
Alzheimer's disease: From immunotherapy to immunoprevention
Jucker, M., & Walker, L. C. (2023) · Cell · doi:10.1016/j.cell.2023.08.021 · Cited by 353
Blood neurofilament light: a critical review of its application to neurologic disease
Barro, C., Chitnis, T., & Weiner, H. L. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51234 · Cited by 296
Frontotemporal Dementia, Where Do We Stand? A Narrative Review
Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 145
Metadata
- Authors
- Gafson, A. R., Barthélemy, N. R., Bomont, P., Carare, R. O., Durham, H. D., Julien, J.-P., Kuhle, J., Leppert, D., Nixon, R. A., Weller, R. O., Zetterberg, H., & Matthews, P. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 143
- Issue
- 7
- Pages
- 1975-1998
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3024239323
- Cited by
- 325
- References
- 231
- FWCI
- 16.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.